Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CSL
Pharma
White House unveils next round of MFN drug pricing deals
At the dealmaking table this time are Alcon, Astellas, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva and UCB.
Fraiser Kansteiner
Aug 31, 2026 5:10pm
CSL projects a return to growth for plasma unit Behring
Aug 18, 2026 11:35am
EU regulators offer post-mortem of Tavneos withdrawal decision
Aug 14, 2026 11:04am
Sanofi offers commitments to end EU flu shot antitrust probe
Jul 8, 2026 4:26pm
EC begins antitrust probe into Sanofi's flu shot campaign
Jun 26, 2026 11:20am
CSL cuts FY26 revenue projection by $600M, writes off $5B
May 11, 2026 11:30am
